Innovative immunotherapy company CERo Therapeutics (NASDAQ:CERO) priced its “reasonable best efforts” public offering with participation from a member of the…
Massimo GiachettiBionano Genomics (NASDAQ:BNGO) stock rallied 19% Friday afternoon after the company announced a $10M registered direct offering priced at-the-market…